Sustained acoustic medicine provides proven soft tissue healing via ZetrOZ's patented wearable ultrasound unit.
Sustained acoustic medicine provides proven soft tissue healing via ZetrOZ's patented wearable ultrasound unit
Attending PHATS since 2014, this year, ZetrOZ showcased sam® X1 and 2.0 to educate attendees on the benefits of sustained acoustic medicine for hockey professionals.
Sustained acoustic medicine delivered by wearable ultrasound device and topical diclofenac patch reduced patients' pain and improved clinical outcomes beyond traditional patient care.
Displayed the advantages of the sam X1 device as a faster way for patients to repair and recover from soft-tissue injuries before returning to work or play.
New study shows sports medicine providers conclude sustained acoustic medicine speeds injury healing and reduces need for pain medication
Studies show hamstring and UCL injuries are most common in opening weeks, and sustained acoustic medicine is effective treatment for those soft-tissue injuries.
Clinical investigator and regenerative medicine pioneer Don Buford, MD, is leading the charge to bring the latest advances in mechanobiology and regenerative medicine to 32.5 million knee arthritis sufferers across the United States in a National Institutes of Health-funded study aimed at reducing opioids and surgery.
CEO George K. Lewis to make a presentation on sustained acoustic medicine and review the sam technology at the healthcare conference.
The sam® breakthrough technology accelerates athletes' soft tissue healing and recovery time through long-duration ultrasound treatment
The long-duration soft-tissue repair ultrasound device provides healthcare professionals with another proven method of accelerating and enhancing healing.
Sustained acoustic medicine brings relief to professional and collegiate tennis players by promoting soft tissue healing.
The Interventional Orthobiologics Foundation Conference is one of the largest gatherings of orthopedic and interventional pain specialists in the United States with a focus on innovation
The conference provides continuing education and facilitates communication among interested sports medicine professionals.
Creator of wearable sustained acoustic medicine technology to educate clinicians on device's effectiveness in soft tissue healing and regenerative medicine treatment.
The sam®x1 is an effective tool for treating acute musculoskeletal injuries and the first wireless long-duration ultrasound system that is FDA-cleared for prescription home use.
The Ambassador Program seeks athletic trainers and social media influencers, amateurs and professionals alike, to promote the proven real-world benefits of sustained acoustic medicine.
The device's ease of use permits players to wear sam® for long periods discreetly, allowing athletes to attend class while maintaining 100% treatment compliance during recovery.
The lunch and lecture provided scientific updates on sustained acoustic medicine research in sports medicine, significant product innovations, and the new 2023 Player Performance Package (PPP).
The sam®x1 wireless sustained acoustic medicine device helps sports and regenerative medicine providers return their patients to everyday activities.
The specialized ultrasound treatment is now available to medical professionals across the United States.
Board-certified physicians use the ZetrOZ Systems sustained acoustic medicine device for injury healing and pain relief without invasive surgery or potentially addictive and dangerous medications.
First-year graduate students at Merrimack College taking Therapeutic Modalities will learn about the effects and benefits of long-duration, sustained acoustic medicine (sam®) on soft-tissue healing.
ZetrOZ's sam®️ technology promotes soft tissue healing, helping patients return to work sooner and preventing more severe injuries; the only FDA-cleared home-use multi-hour ultrasound stimulator.
ZetrOZ Systems will showcase its sustained acoustic medicine (sam®) technology, a non-invasive, non-systemic treatment option for soft-tissue injuries experienced in the workplace and beyond. The companies' partnerships with self-insured and insurance providers has expanded access to millions of lives in America.
The wireless, long-duration, continuous, ultrasound, patch-based stimulator delivers 33 times more treatment than pulsed ultrasound devices and is authorized by the FDA for prescription home use in the United States of America.
The wearable sustained acoustic medicine (sam®) treatment has been effectively utilized by sports medicine doctors, athletes and beyond to help rapidly treat tendon, ligament and other soft-tissue injuries.
A sam® regimen prioritizes healing beyond the pain to emphasize the importance of returning patients fully back to health to minimize the risk of chronic, recurring injuries.
New clinical research sheds light on the use of sam®, a medical ultrasound device for prescription home use, for pain mitigation in soft tissue injuries.
At a recent conference of professional hockey trainers, ZetrOZ Systems, a leading innovator and inventor of sustained acoustic medicine (sam®) for soft tissue injury healing, presented results of studies indicating the medical device is highly effective at treating the types of injuries hockey players frequently experience.
sam® by Zetroz Systems utilizes high-frequency, low-intensity continuous ultrasound to facilitate the healing of injured musculoskeletal tissue in the home of the patient.
Effective management of a company's intellectual property can create significant advantages, crucial in today's competitive health technology marketplace.
Creator of sustained acoustic medicine soft tissue healing device reports that even FDA-cleared devices backed by body of research and millions of successful treatments still face hurdles.
ZetrOZ Systems' musculoskeletal ultrasound device facilitates return to regular activities
Sustained Acoustic Medicine Inventors ZetrOZ Systems Outlines How Patients and Providers Can Work Together in Accessing Healthcare Benefits
Innovative medical technologies like the sam® device promote soft tissue healing
Sustained Acoustic Medicine developer avoids supply chain tangles to supply healthcare providers with needed medical intervention.
New research demonstrates how sustained acoustic medicine (SAM) accelerates healing and recovery from soft tissue injury common in college and professional sports
Innovative, wearable, FDA-cleared long-duration ultrasound device proven effective in rehabilitation and pain management, medical journal review reports.
Dr. George Lewis, inventor of sam® soft tissue healing pain relief ultrasound device, to review 2022 clinical research on technology and patient outcomes
Cutting-edge sustained acoustic medicine soft tissue healing treatment developed in partnership with federal research support will now help federal workers recover from injury and improve surgery outcomes.
Wearable ultrasound sam® device heals soft tissue injuries faster, reduces need for surgery and pain medications.
Groundbreaking ultrasound therapy company helps the Whale and other sports teams recover, manage pain and stay in the game
Sustained acoustic medicine (sam®) device for soft tissue injuries is available for patients and healthcare providers to amplify the body's natural ability to heal by increasing local circulation
Wearable ultrasound technology from ZetrOZ Systems meets patients' need for for drug-free, non-invasive treatment extending healing to the home
Wearable ultrasound therapy for home use assists in healing and reduces reliance on narcotic pain medications, which only mask pain
The pain management ultrasound device helps heal injuries and return employees back to work without surgery or narcotics.
ZetrOZ's Sustained Acoustic Medicine (samⓇ) backed by 15 years of research, 30 clinical studies, 300,000 patients